Algert Global LLC Has $3.01 Million Position in VAREX IMAGING $VREX

Key Points

• Algert Global LLC increased its stake in VAREX IMAGING by 52.9%, acquiring an additional 89,811 shares to bring its total holdings to 259,609 shares valued at approximately $3 million.
• VAREX IMAGING reported $0.18 earnings per share for the last quarter, surpassing analysts' expectations of $0.04, alongside revenue of $203 million which also exceeded estimates.
• Analysts maintain a consensus "Buy" rating for VAREX IMAGING, with B. Riley raising its target price from $12.00 to $16.00, while the average price target stands at $19.50.

Algert Global LLC grew its holdings in VAREX IMAGING (NASDAQ:VREX - Free Report) by 52.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 259,609 shares of the company's stock after purchasing an additional 89,811 shares during the period. Algert Global LLC owned approximately 0.63% of VAREX IMAGING worth $3,011,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Nuveen Asset Management LLC raised its holdings in shares of VAREX IMAGING by 0.5% during the fourth quarter. Nuveen Asset Management LLC now owns 161,344 shares of the company's stock worth $2,354,000 after acquiring an additional 791 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of VAREX IMAGING by 4.1% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,072 shares of the company's stock worth $322,000 after acquiring an additional 864 shares in the last quarter. Barclays PLC raised its holdings in shares of VAREX IMAGING by 1.1% during the fourth quarter. Barclays PLC now owns 98,964 shares of the company's stock worth $1,444,000 after acquiring an additional 1,081 shares in the last quarter. Aquatic Capital Management LLC purchased a new stake in shares of VAREX IMAGING during the fourth quarter worth $25,000. Finally, MetLife Investment Management LLC raised its holdings in shares of VAREX IMAGING by 8.5% during the fourth quarter. MetLife Investment Management LLC now owns 24,026 shares of the company's stock worth $351,000 after acquiring an additional 1,890 shares in the last quarter.

Wall Street Analysts Forecast Growth

VREX has been the subject of several recent research reports. B. Riley reiterated a "buy" rating and set a $16.00 price objective (up from $12.00) on shares of VAREX IMAGING in a report on Friday, August 8th. Wall Street Zen lowered VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $19.50.

VAREX IMAGING Stock Down 1.1%

VAREX IMAGING stock traded down $0.12 during mid-day trading on Tuesday, hitting $11.28. 321,858 shares of the company's stock were exchanged, compared to its average volume of 561,002. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78. The stock has a market cap of $468.12 million, a P/E ratio of -3.51 and a beta of 0.68. VAREX IMAGING has a 1-year low of $6.76 and a 1-year high of $16.93. The stock has a 50 day moving average of $8.68 and a two-hundred day moving average of $9.48.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.04 by $0.14. The firm had revenue of $203.00 million for the quarter, compared to the consensus estimate of $190.32 million. VAREX IMAGING had a negative net margin of 16.13% and a positive return on equity of 5.54%. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. As a group, analysts anticipate that VAREX IMAGING will post 0.53 EPS for the current fiscal year.

VAREX IMAGING Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.